Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Udi: (b)(4).Investigation summary: the complaint device was received and inspected.The complaint can be confirmed.A visual inspection was performed to reveal any gross visual defects that may contribute to the complaint condition.It was observed that the actuator was free from the handle assembly at the proximal end.A functionality check of the device confirmed that the actuator could not open or close the upper jaw of the device as the trigger assembly was pushed or pulled.This type of failure is typically observed when the user grasps excessive amounts of suture in the jaw of the device, therefore placing excessive stress on the actuator assembly.When this occurs, the shear pin can break at the proximal end which holds the actuator to the trigger therefore is a potential root cause for the reported failure.However, given the information provided we cannot discern a definitive root cause for the reported failure.At this point, no corrective action is required and no further action is warranted.However, depuy synthes mitek will continue to track any related complaints within this device family as a means of monitoring the extent with which this complaint is observed in the field.This report is being filed as required under mitek's corrective and preventative actions (capa) to file usa fda mdr missed malfunctions.
|
It was reported by the affiliate in (b)(6) that during shoulder repair arthroscopy, it was observed that the opening / closing mechanism on the arthro grasper pen 35 up *ea device was not working.The procedure was completed with a second device with no patient harm, but with a five to ten minute delay.There was a delay in the surgical procedure.There was a spare device available for use to complete the surgery.There was patient involvement.There were no reports of injuries, medical intervention or prolonged hospitalization.All available information has been disclosed.If additional information should become available, a supplemental medwatch will be submitted accordingly.
|